- authorisedTherapeutic confirmatory (Phase III)
A randomized, open-label, multicenter, Phase 3 study to investigate mocertatug rezetecan compared with chemotherapy in participants with endometrial cancer after platinum-based chemotherapy and immunotherapy
This Phase 3 clinical trial tests a new drug called mocertatug rezetecan for womb (endometrial) cancer. Researchers want to see if it works better and is safer than standard chemotherapy for people whose cancer has returned or worsened after earlier treatments like platinum chemotherapy and immunotherapy.
Denmark · Netherlands · Italy - recruitingPHASE3
A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
This study looks at a new drug, mocertatug rezetecan (Mo-Rez), for womb cancer that has come back after standard treatments. Researchers want to see if Mo-Rez works better and is safer than chemotherapy for people who have already tried other medicines for their cancer.
United States · Argentina · Australia